Edap TMS SA (EDAP)
2.47
-0.02
(-0.80%)
USD |
NASDAQ |
Nov 22, 16:00
2.47
0.00 (0.00%)
After-Hours: 20:00
Edap TMS Free Cash Flow: -24.95M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -24.95M |
| June 30, 2024 | -20.87M |
| March 31, 2024 | -20.17M |
| December 31, 2023 | -20.54M |
| September 30, 2023 | -22.46M |
| June 30, 2023 | -18.07M |
| March 31, 2023 | -11.71M |
| Date | Value |
|---|---|
| December 31, 2022 | -5.636M |
| September 30, 2022 | 4.236M |
| June 30, 2022 | 3.257M |
| March 31, 2022 | 2.327M |
| December 31, 2021 | 3.312M |
| September 30, 2021 | 0.8892M |
Free Cash Flow Range, Past 5 Years
-24.95M
Minimum
Sep 2024
4.236M
Maximum
Sep 2022
-10.03M
Average
-11.71M
Median
Mar 2023
Free Cash Flow Benchmarks
| DBV Technologies SA | -108.72M |
| Cellectis SA | 60.38M |
| Genfit SA | -- |
| Adaptimmune Therapeutics PLC | -56.05M |
| Akari Therapeutics PLC | -14.84M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.573M |
| Cash from Investing (Quarterly) | -1.120M |
| Cash from Financing (Quarterly) | 0.6422M |
| Free Cash Flow Per Share (Quarterly) | -0.1797 |
| Free Cash Flow to Equity (Quarterly) | -7.677M |
| Free Cash Flow to Firm (Quarterly) | -6.693M |
| Free Cash Flow Yield | -27.21% |